Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-03-29
2005-03-29
Jones, Dwayne (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S248000
Reexamination Certificate
active
06872722
ABSTRACT:
This invention relates to therapeutic methods for treatment or prevention of tissue damage resulting from ischemia in mammals.
REFERENCES:
patent: 4251528 (1981-02-01), Brittain et al.
patent: 4939140 (1990-07-01), Larson et al.
patent: 4996204 (1991-02-01), Mylari et al.
patent: 5506228 (1996-04-01), Norton et al.
patent: 5670504 (1997-09-01), Bochis et al.
patent: 5834466 (1998-11-01), Ramasamy et al.
patent: 6579879 (2003-06-01), Mylari
patent: 6730674 (2004-05-01), Martin et al.
patent: 20030004139 (2003-01-01), Martin et al.
patent: 1043317 (2000-10-01), None
patent: 1236720 (2002-09-01), None
Tracey, et al., Am J. Physiol Heart Circ. Physiol, 279, pp. H1447-H1452, 2000.
Ramasamy, et al., Diabetes, vol. 46, Feb. 1997, pp. 292-300.
Patent Abstracts of Japan, vol. 014, No. 014 (C-674), 1990 & JP 01 258671A (Morishita Seiyaku KK), 1989, Abstract.
Benson Gregg C.
Jones Dwayne
Mulholland William F.
Pfizer Inc
LandOfFree
Therapies for tissue damage resulting from ischemia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapies for tissue damage resulting from ischemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapies for tissue damage resulting from ischemia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3423081